Healthcare Analytics

AmerisourceBergen Announces Pharmacy Telehealth Partnership with SteadyMD

businesswire | May 05, 2023 | Read time : 02:00 min

AmerisourceBergen Announces

AmerisourceBergen (AB), a global healthcare company, has announced a strategic partnership with SteadyMD, a B2B telehealth infrastructure provider that powers high-quality telehealth patient experiences for leaders and innovators in healthcare. The two organizations have kicked off their collaboration with the cocreation of a telehealth solution focused on Test to Treat opportunities. The solution is being offered as a pilot to independent community pharmacies across the US.

“The Test to Treat initiative is an important acknowledgement of the role of pharmacists and pharmacies as accessible healthcare providers and destinations,” said Jenni Zilka, Senior Vice President, Good Neighbor Pharmacy Field Programs & Services at AmerisourceBergen. “In order for pharmacies to continue making a sustainable impact on the communities they serve, we need to continue providing them the tools, resources, and authority to provide necessary clinical services, where appropriate. AmerisourceBergen’s exploration of a telehealth solution with SteadyMD to enhance the scope of the Test to Treat model is just one way we’re continuing to support the important role of the pharmacist in the healthcare ecosystem.”

AmerisourceBergen’s telehealth solution is being developed to expand the number of Test to Treat services that independent pharmacies can offer to patients. The Test to Treat initiative was launched in 2022 to help provide quick and equitable access to COVID-19 testing and treatment in the early days of infection. The model is intended to provide a seamless patient experience and designed to reach high-risk, underserved populations.

With its telehealth solution, AmerisourceBergen is evaluating the long-term viability of the Test to Treat model for use cases, beyond COVID-19, to improve access to treatment. The pilot program has been launched across a group of 130 independent retail pharmacies, including members of the Good Neighbor Pharmacy network. Over a span of 12 weeks, pilot participants will utilize the SteadyMD platform to provide patients with a quick and accessible Test to Treat option within their pharmacy, at an affordable price. Patients can test for an illness or condition and then, if deemed necessary by a SteadyMD physician, consult with them on demand through the telehealth platform and receive a prescription for treatment.

"We're excited to embark on a commercial partnership with AmerisourceBergen and welcome the company to our supportive family of investors," said Guy Friedman, CEO of SteadyMD. "As we continue our mission to save leaders and innovators in healthcare time, money, and resources by helping them stand up their telehealth practices, AmerisourceBergen’s collaboration and investment will further strengthen our best-in-class technology, clinical operations, and nationwide clinician workforce, while bolstering our unwavering commitment to becoming the backbone powering modern healthcare."

“AmerisourceBergen has an ongoing commitment to delivering innovation for its customers and aligning with organizations that are transforming healthcare through bold thinking, solutions, and programs,” said Jason Dinger, SVP of Global Product and Solutions at AmerisourceBergen. “Working with SteadyMD, we look forward to collaborating on a telehealth offering to help our pharmacy customers drive value for their patients and their bottom lines.”

Pharmacies participating in the telehealth pilot program can use the solution to help patients obtain COVID-19 oral antiviral therapies, as appropriate. AmerisourceBergen and SteadyMD will continuously evaluate opportunities to expand use cases during and after the program.

In addition to the commercial partnership, AmerisourceBergen has also made an investment in SteadyMD through its venture fund AB Health Ventures.

About AmerisourceBergen

AmerisourceBergen is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 44,000+ worldwide team members contribute to positive health outcomes through the power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue.


Discover how the integration of innovative technological solutions and a deep understanding of the specific needs of the healthcare sector can drive efficiency, security, and quality in healthcare delivery.


Discover how the integration of innovative technological solutions and a deep understanding of the specific needs of the healthcare sector can drive efficiency, security, and quality in healthcare delivery.

Related News

Health Technology, Digital Healthcare

EPIC Health Launches New Remote Patient Monitoring Program in Collaboration with OMRON Healthcare to Address Health Inequities with VitalSight™

prweb | August 11, 2023

EPIC Health, Detroit's health system committed to community-focused healthcare, and OMRON Healthcare, a global heart health leader, today announced a new collaboration to address health inequities and reduce heart attack and stroke risk in underserved Detroit communities. The program will feature VitalSight™, OMRON's first remote patient monitoring service designed specifically for patients afflicted by high blood pressure and especially those with uncontrolled Stage 2 hypertension. "We developed VitalSight to empower patients with the technology and tools to monitor their blood pressure from home, share their data with their doctors, and gain a greater sense of understanding about high blood pressure, how to manage it, and ways to reduce their health risk," said OMRON Healthcare President and CEO Ranndy Kellogg. "With EPIC Health, we have a collaborative partner who shares our Going for Zero mission to eliminate heart attack and stroke and is dedicated to addressing the health inequities that often magnify health risks for patients in underserved communities." VitalSight is an easy-to-use remote patient monitoring service that physicians can offer to patients with high risk levels of hypertension. More than 37 million U.S. adults1 have uncontrolled Stage 2 hypertension that can contribute to increased risk of heart attack and stroke, which could lead to artery and organ damage if no treatment is administered2. Patients are enrolled in VitalSight by a healthcare provider. The service is available to patients at little to no cost and is reimbursable through Medicare. Patients who are enrolled in the program by EPIC Health physicians receive the VitalSight kit delivered to their home. The kit includes an OMRON connected blood pressure monitor, a weight scale (if requested by the clinician), and a data hub that are all pre-set for the specific patient. With VitalSight, EPIC Health clinicians can personalize blood pressure reading thresholds for each patient and receive alerts for out-of-range readings so care teams can take action and make more informed treatment decisions. "The VitalSight data hub is a key asset because it works without home Wi-Fi. Our patients can monitor their blood pressure easily from home and securely share readings with their care teams," said Dr. Greg Naman, MD, Board-Certified in Internal Medicine and Pediatrics, EPIC Health. "VitalSight connects us more with the patient and helps us spotlight key data. As a medical professional working to bridge health gaps, it's a boost to have a service that makes data actionable – the patient is more engaged in managing their condition and the care team has more insights to evolve treatment." "EPIC Health remains diligent in its efforts to increase and improve dialogue between patients and physicians, address growing populations impacted by hypertension and stroke, and increase health access for all," said Dr. Naman. "OMRON's Going for Zero mission and innovative technology makes them an excellent partner in this program." About OMRON Healthcare, Inc. OMRON Healthcare, Inc., is the world's leading manufacturer and distributor of personal heart health products and an innovator in technologies supporting respiratory and pain management care. With 50 years of medical device category leadership, OMRON is passionate about empowering people to take charge of their health at home through precise technology. Its market-leading products include a full range of home blood pressure monitors, nebulizers, and TENS devices. The company's mission is Going for Zero, the elimination of heart attacks and strokes. With well over 300 million devices sold globally, OMRON provides the world's most recommended blood pressure monitors by healthcare professionals. OMRON Healthcare has always strived to improve lives and contribute to a better society by developing innovations that help people prevent, treat, and manage their medical conditions, and we provide products and services in over 110 countries. About EPIC Health Headquartered in Southfield, MI, EPIC Health is a multi-specialty network of primary care practices with multiple locations in southeast Michigan. With a mission of providing high-end care everywhere to everybody, EPIC provides comprehensive healthcare to its patients and members of the surrounding communities. Founded in 2000, EPIC distinguishes itself with its unique approach to healthcare access, and its vision to be the trusted global center of excellence for complex care and prevention through innovation, integration, and continuous improvement.

Read More

Healthcare Analytics

GE HealthCare Releases Sustainability Report, Shares Future Goals

GE HealthCare | September 25, 2023

First Sustainability Report since January 2023 showcases the company’s commitment to creating a world with no healthcare limits Report shows reduced operational Scope 1 and 2 greenhouse gas emissions by 27% since 2019 Strong leadership focus on sustainability efforts and ESG with a cross-functional ESP GE HealthCare has released its inaugural Sustainability Report, marking its commitment to environmental, social, and governance (ESG) practices since becoming an independent company in January 2023. The report highlights the reduction of operational Scope 1 and 2 greenhouse gas emissions by 27% since 2019 and outlines the company's dedication to ESG principles and sustainability. GE HealthCare recognizes the importance of sustainability and corporate responsibility in the healthcare industry. The report reflects the company's dedication to creating a world where healthcare knows no limits and its commitment to environmental and social impact. ESG Program Leader at GE HealthCare, Kelvin Sanborn, stated, GE HealthCare recognizes the global significance of fulfilling our purpose and delivering on our objectives and is pleased to have reduced our operational GHG emissions by 27% versus our 2019 baseline. With our broad ESG strategy and priorities in mind, we are carrying out a climate risk assessment that will inform our climate transition plan, and developing a net zero roadmap for Scope 1, 2, and 3 GHG emissions. [Source: Business Wire] Key Highlights from the Company's Inaugural Sustainability Report: Environmental Impact Since 2019, reduced GHG emissions by 27% with goals of 50% reduction by 2030 and net zero by 2050 Registered with Science Based Targets Initiative Committed to decarbonizing the healthcare sector Social Impact Established cultural operating principles Planned GE Healthcare Foundation for philanthropy Appointed chief diversity, equity, and inclusion officer Governance and Accountability Strong corporate governance as a stand-alone public company Relaunched Code of Conduct with high employee engagement Joined UN Global Compact to support sustainable development goals GE HealthCare conducted an ESG materiality assessment, defining five key focus areas for its sustainability strategy. These include expanding healthcare access, fostering diversity and inclusion, reducing greenhouse gas emissions, promoting the circular economy, and enhancing patient data cybersecurity. The report outlines the company's long-term ESG objectives and progress toward previous goals. It is preparing to release an updated task force on climate-related financial disclosures (TCFD) report once its climate risk assessment is finalized. Furthermore, the company has scheduled a materiality assessment update for 2024. In parallel, GE HealthCare is exploring the expansion of Reporting Standards for its ESG disclosures and evaluating how its objectives align with the United Nations Sustainable Development Goals (UN SDGs). After conducting an ESG materiality assessment before its spin-off, the company has pinpointed five vital areas for its sustainability strategy. These priorities, underscored by the company's core innovation, product quality, and integrity principles, encompass the following: Expanding global healthcare access by ensuring underserved populations have better healthcare opportunities; promoting a culture of inclusion and diversity; mitigating its climate impact through concerted efforts; facilitating equipment and prioritizing patient data security and cybersecurity by adhering to standardized data privacy and security practices based on global regulations such as the EU GDPR.

Read More

Health Technology, Healthcare Analytics

AmeriPro Health expands to Kentucky and Indiana with acquisition of AMR's operations

prnewswire | August 07, 2023

AmeriPro Health, a leading provider of patient logistics and last-mile healthcare delivery services, has acquired American Medical Response, Inc.'s (AMR) operations in Lexington and Louisville, Kentucky, and New Albany, Indiana. As a result of the acquisition, AmeriPro Health now provides these three markets, which include UofL Health, University of Louisville Athletics and UK HealthCare, with its customizable suite of patient-centric 911, inter-facility medical transportation, critical care and advanced life support (ALS) services. "We're thrilled to bring AmeriPro's innovative last-mile services to Lexington, Louisville and New Albany," says Suhas Uppalapati, CEO of AmeriPro Health. "AmeriPro is steadfast in our commitment to revolutionize patient logistics. We aim to provide members of these communities - and blue-chip institutional partners such as UK HealthCare and UofL Health, along with other local hospitals, health plans and employers - with unmatched patient health services." This news follows AmeriPro's 2022 acquisition of CareMed, an ambulance service provider in Mississippi and Tennessee, and Ambulance Service, Inc., a longstanding Jacksonville, Florida-based EMS provider, in 2019. Established in 2018 with 10 ambulances in the Metro Atlanta area, AmeriPro Health has rapidly grown to 800+ employees with operations across six states. About AmeriPro Health AmeriPro Health encompasses a diverse range of healthcare companies devoted to optimizing patient logistics and last-mile healthcare delivery. Our extensive portfolio comprises emergency and critical care services, non-emergency medical transportation, patient coordination and personalized home-based care solutions, providing a seamless patient care journey. By covering the complete spectrum of patient care, we ensure enhanced patient outcomes, more efficient healthcare processes and timely, location-appropriate access to care. At AmeriPro Health, we provide an adaptable suite of patient-centric, value-driven services, tailored to meet the needs of communities, health systems, health plans and employers. As a pioneer in last-mile healthcare, our strength lies in our capacity to anticipate future needs, swiftly adapt and deliver on the evolving demands of our clients.

Read More